Skip to Main Content

Paper Details

Recombinant spike protein vaccines coupled with adjuvants that have different modes of action induce protective immunity against SARS-CoV-2.
Vaccine
0
2023
Author NameAffiliation
Yoshihiro KawaokaInfluenza Research Institute, University of Wisconsin-Madison, Institute of Medical Science, University of Tokyo, Japan The Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute, Infection and Advanced Research Center, The University of Tokyo
  • 1 - 1

Datasets